LACOSAMIDE
NDC 31722-203, LACOSAMIDE, injection, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-203
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216335
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/31722-203 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-203-31 | 31722020331 | 10 VIAL, GLASS in 1 CARTON (31722-203-31) / 20 mL in 1 VIAL, GLASS (31722-203-20) |
| 31722-203-33 | 31722020333 | 10 VIAL, GLASS in 1 CARTON (31722-203-33) / 20 mL in 1 VIAL, GLASS (31722-203-32) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e24d3c45-a559-4fca-a7be-74ce37a7066e
Use it
Look up 31722-203 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-203 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-203. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.